Subscribe to
this category


A total of 32 posts are filed under Finance
Generation Bio Raises $100 Million to Advance Re-Dosable Gene Therapy
Rare Daily Staff Generation Bio said it closed a $100 million series B financing to advance to the clinic its first two therapeutics… Continue Reading
Minoryx Therapeutics Spins Off See-Tx Platform to Create Gain Therapeutics
Rare Daily Staff Minoryx Therapeutics said it has spun off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform to form Gain… Continue Reading
Tremeau Closes $5.2 Million Equity Round to Repurpose Vioxx for Rare Diseases
Rare Daily Staff Tremeau Pharmaceuticals said that it raised a total of $5.2 million in its first equity round to advance its pipeline of… Continue Reading
Gene Therapy Developer Avrobio Closes $60 Million Financing
Rare Daily Staff Gene therapy developer Avrobio said that it has completed a $60 million series B financing, which will be used to advance… Continue Reading
Solid Biosciences IPO Raises $133.7 Million, but Former Scientific Advisory Board Member Raises Safety Concerns
Rare Daily Staff Solid Biosciences said it closed its initial public offering of more than 8.9 million shares of common stock at $16 per… Continue Reading
Scholar Rock Announces $47 Million Series C Financing to Pipeline
Rare Daily Staff Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively modulate growth factor… Continue Reading
Aura Biosciences Completes $30 Million Funding Round
Rare Daily Staff Aura Biosciences, which is developing a new class of therapies to target and selectively destroy cancer cells using viral… Continue Reading
1 2 3 5